SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: vestor1/5/2001 7:55:05 PM
   of 315
 
Candela Introduces Smoothbeam Skin Renewal Laser At IMCAS; Presentation
of Diode Laser for Non-Ablative Dermal Remodeling

WAYLAND, Mass., Jan 5, 2001 (BUSINESS WIRE) -- Candela Corporation
(NASDAQ:CLZR) will introduce the Smoothbeam, a revolutionary new non-ablative
diode laser technology for skin renewal, on January 12, 2001 at the
International Master Course on Ageing Skin (IMCAS) in Paris, France.

At IMCAS's Cutaneous Multilaser Master Workshop on Friday, January 12, at 8:00
p.m. in the Maillot Room, Dr. Dilip Paithankar will discuss the new Smoothbeam
laser in his presentation, 1.45(mu) Diode Laser for Non-Ablative Dermal
Remodeling.

Commenting on the introduction, Gerard E. Puorro, Candela's President and CEO,
remarked: "Smoothbeam represents a whole new way to approach skin renewal.
Smoothbeam will enable physicians to offer non-ablative skin renewal services to
their patients at a fraction of the cost of competing laser systems."

Smoothbeam's unique LASR (Laser Assisted Skin Renewal) process offers
proprietary Candela technology for collagen remodeling. Its unique wavelength
heats the upper dermis, inducing a mild thermal injury. The body's natural
healing response initiates collagen remodeling and the deposition of new,
organized collagen.

Dr. Dilip Paithankar, Senior Scientist at Candela Corporation noted: "Smoothbeam
is unique in that the wavelength it offers enables one to localize thermal
injury to the upper dermis which is closer to the skin's surface providing more
visible results. Smoothbeam also delivers multiple cryogen sprays for effective
epidermal preservation."

Smoothbeam features Candela's integrated Dynamic Cooling Device (DCD)(TM), which
cools and protects the epidermis prior to, during and post laser exposure. DCD
automates the delivery of cryogen to localize thermal injury to the upper
dermis.

No post-treatment care means that anatomic treatments around the eyes and upper
lip can be given quickly and easily with minimal downtime for patients. Weighing
less than 40 pounds, Smoothbeam is a tabletop unit - simple to use and operate,
easy to transport and store.

In addition to Dr. Paithankar's address on Friday evening, interested physicians
and press can learn about the new Smoothbeam at Candela Booth #41 at the IMCAS
exhibition hall.

About Candela:

Candela Corporation develops, manufactures, and distributes innovative clinical
solutions that enable physicians, surgeons, and personal care practitioners to
treat selected cosmetic and medical conditions using lasers, aesthetic laser
systems, and other advanced technologies. Founded near Boston in 1970, Candela
markets and services its products in over 50 countries from offices in the
United States, Europe, Japan and Asia. Candela established the aesthetic laser
market 12 years ago, and currently has an installed base of over 4,000 lasers
worldwide. Candela is an Equal Opportunity and Affirmative Action Employer,
M/F/H/V.

Safe Harbor Statement:

Safe Harbor Statement - Except for the historical information contained herein,
this news release contains forward-looking statements that constitute Candela's
current intentions, hopes, beliefs, expectations or predictions of the future
which are, therefore, inherently subject to risks and uncertainties. Candela's
actual results could differ materially from those anticipated in Candela's
forward-looking statements based on various factors, including without
limitation: cancellation or deferral of customer orders, total dependence on a
small number of strategic distribution relationships, difficulties in the timely
development and market acceptance of new products, market developments that vary
from the current public expectations concerning the growth of the laser
industry, increased competitive pressures, or changes in economic conditions.
Further information on factors that could affect Candela's performance is
included in Candela's periodic reports filed with the SEC, including but not
limited to Candela's Form 10-K (or any amendment thereto) for the year ended
July 1, 2000, and subsequent Forms 10-Q. Candela cautions readers not to place
undue reliance upon any such forward-looking statements, which speak only as of
the date made. Candela expressly disclaims any obligations or undertaking to
release publicly any updates or revisions to any such statements to reflect any
change in Candela's expectations or any change in events, conditions or
circumstance on which any such statement is based.

CONTACT: Candela Corporation
Jane Smith, 508-358-7400 x247
or
Seidler Bernstein
Luise Cahill, 781-235-2782

URL: businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext